Anuh Pharma Ltd.

•

anuhpharma.comBSE: 506260NSE: ANUHPHR

Market Cap₹ 814 Cr.

Current Price

High / Low₹ 93 / 67

Stock P/E18.4

Book Value₹ 36

Price to Book1.91

Dividend Yield1.85 %

ROCE16.0 %

ROE12.1 %

Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has a healthy return on capital (ROCE) of 21.8%
Latest quarter profit grew 37.7% YoY, showing strong momentum
Company has been maintaining a healthy dividend payout of 36.6%
Company generates healthy free cash flow
Company has a consistent dividend-paying track record

CONS

Operating cash flow has been negative in recent years
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.32x)
Valuation is stretched - P/E of 18.4 is well above its own 5-year median (10.2)
Company has delivered a poor profit growth of 7.6% over past five years
Operating margins have contracted to 7.4% from 10.9%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ANUHPHR	81.24	18.43	814.22	1.85	114.25	1276.51	1938.10	939.31	16.02	8.40

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	161	150	172	164	138	166	160	198	186	186	197	202	1,938
	148	132	148	145	127	149	145	179	176	174	180	182	1,800
Operating Profit	14	18	24	19	11	17	15	19	10	12	17	20	139
OPM %	8.65%	12.01%	13.94%	11.73%	7.66%	10.17%	9.27%	9.42%	5.52%	6.39%	8.52%	9.84%	7.15%
	3	2	4	3	4	3	1	1	3	1	4	-1	31
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2	2	2	2	2	2	2	3	3	3	3	3	24
Profit before Tax	15	18	25	20	12	18	13	17	11	10	18	16	169
Tax %	23.75%	22.60%	24.46%	22.11%	22.49%	17.32%	22.00%	27.89%	24.20%	23.29%	24.57%	24.74%	32.51%
Net Profit	12	14	19	15	10	15	10	12	8	8	13	12	114
	2.35	2.76	3.81	3.06	1.90	1.50	1.03	1.24	1.66	0.76	1.34	1.17	1.14

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	206	238	321	307	432	487	527	647	662	772	779
	183	220	291	284	387	439	476	571	600	714	717
Operating Profit	23	18	30	23	45	47	52	76	62	57	62
OPM %	11.00%	7.70%	9.34%	7.57%	10.45%	9.75%	9.82%	11.71%	9.30%	7.44%	8.01%
	8	7	5	4	11	5	6	12	9	9	7
Interest	1	0	1	1	2	2	1	1	1	1	0
Depreciation	2	2	2	7	15	12	10	9	9	11	11
Profit before Tax	28	23	32	19	39	39	47	78	61	54	60
Tax %	27.32%	29.49%	27.89%	25.32%	26.24%	21.88%	23.78%	23.31%	22.38%	24.30%	26.63%
Net Profit	20	17	23	14	28	31	36	60	47	41	44
EPS	0.00	0.00	0.00	0.00	5.67	6.10	7.22	11.98	9.45	4.10	—
Dividend Payout %	31.24%	41.73%	29.49%	48.17%	26.43%	28.70%	27.70%	20.86%	15.87%	36.63%	—

COMPOUNDED SALES GROWTH

10 Years:: 9%
5 Years:: 12%
3 Years:: 14%

COMPOUNDED PROFIT GROWTH

10 Years:: 5%
5 Years:: 8%
3 Years:: 4%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: -5%

RETURN ON EQUITY

10 Years:: 15%
5 Years:: 16%
3 Years:: 17%
Last Year:: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	13	13	13	13	25	25	25	25	25	50
	128	137	152	150	166	189	216	266	301	302
	0	2	4	45	14	4	1	2	11	0
Trade Payables	42	52	59	105	120	122	153	141	157	188
	5	4	11	15	8	8	9	11	11	14
Total Liabilities	187	208	239	326	333	347	404	445	505	554
	17	17	21	84	71	61	53	49	58	57
Capital Work in Progress	0	6	34	0	0	0	0	0	0	0
	70	66	39	80	31	43	91	97	106	84
	30	32	43	61	81	80	73	75	74	148
	0	0	0	0	0	0	0	190	216	239
Cash & Bank	6	8	11	3	20	16	7	8	20	8
	63	79	91	99	128	147	181	25	30	18
Total Assets	187	208	239	326	333	347	404	445	505	554

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	34	9	17	54	-9	38	67	13	37	-3
Cash from Investing	-20	2	3	-77	52	-8	-43	1	-20	18
Cash from Financing	-4	-5	-7	22	-33	-19	-12	-9	-5	-26
	2	-1	3	-5	0	2	-2	5	12	-11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	8.00	6.59	9.33	5.71	5.67	6.10	7.22	11.98	9.45	4.10
Book Value (₹)	56.09	59.71	65.69	64.74	38.04	42.66	48.14	58.11	65.06	35.14
Dividend per Share (₹)	2.50	2.75	2.75	2.75	1.50	1.75	2.00	2.50	1.50	1.50
Cash EPS (₹)	2.20	1.83	2.50	2.13	4.34	4.24	4.58	6.85	5.60	5.23
PROFITABILITY
Operating Margin %	13.95%	10.57%	10.76%	8.63%	12.64%	10.73%	10.93%	11.65%	9.23%	7.37%
Net Margin %	9.24%	6.79%	7.25%	4.50%	6.46%	6.22%	6.83%	9.24%	7.10%	5.27%
ROE %	15.43%	11.38%	14.87%	8.75%	16.12%	15.11%	15.90%	22.56%	15.34%	12.10%
ROCE %	21.61%	16.31%	20.56%	10.87%	19.75%	19.33%	21.05%	29.66%	19.77%	16.02%
	10.58%	8.35%	10.44%	5.06%	8.63%	8.99%	9.63%	14.14%	9.97%	7.76%
EFFICIENCY
Debtor Days	110	96	82	89	78	90	106	101	111	106
Inventory Days	45	46	42	60	59	60	53	42	41	52
Payable Days	115	96	84	131	125	117	125	111	109	105
	40	46	41	19	12	33	33	32	43	53
FINANCIAL HEALTH
Debt to Equity (x)	0.00x	0.02x	0.03x	0.27x	0.07x	0.01x	0.00x	0.01x	0.03x	0.00x
Interest Coverage (x)	39.30x	52.91x	55.16x	16.23x	19.99x	25.76x	64.61x	82.82x	50.10x	57.78x
	2.91x	2.63x	2.03x	1.37x	1.70x	1.98x	1.91x	2.22x	2.11x	2.22x
GROWTH
Revenue Growth %	-36.81%	15.49%	34.68%	-4.27%	40.72%	12.66%	8.39%	22.66%	2.24%	16.65%
Operating Profit Growth %	-26.27%	-15.11%	34.87%	-20.82%	102.79%	-5.38%	9.98%	51.68%	-19.20%	-6.24%
Net Profit Growth %	-22.30%	-17.65%	41.51%	-38.78%	98.78%	7.47%	18.38%	66.00%	-21.16%	-13.32%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	66.00%	-21.16%	-56.66%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	10.25x	7.88x	16.39x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	4.23x	2.29x	1.91x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.02%	1.01%	2.23%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	13.94x	10.38x	9.98x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	69.92	69.92	69.92	69.92	69.92	71.82	71.82	71.80	71.80
	0.03	0.02	0.02	0.04	0.04	0.00	0.00	0.05	0.01
DIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	30.05	30.06	30.06	30.05	30.04	28.18	28.18	28.16	28.19

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-19

Investor Presentation

2026-08-19 - Anuh Pharma Limited has informed the Exchange about Investor Presentation

2026-08-14

Change in Management

2026-08-14 - Anuh Pharma Limited has informed the Exchange about change in Management

2026-08-14

Appointment

2026-08-14 - Anuh Pharma Limited has informed the Exchange regarding Appointment of Mr Bipin N. Shah, Mr. Arun L. Todarwal and Mr. Ankit Chande as Directors of the company.

2026-08-14

General Updates

2026-08-14 - Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30.

2026-08-14

Shareholders meeting

2026-08-14 - Anuh Pharma Limited has submitted the Exchange a copy Voting Results and Scrutinizers report of Annual General Meeting held on August 12, 2026.

2026-08-12

Shareholders meeting

2026-08-12 - Anuh Pharma Limited has informed the Exchange regarding Proceedings of 66th Annual General Meeting held on August 12, 2026

2026-08-09

Copy of Newspaper Publication

2026-08-09 - Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Unaudited financial results for the Quarter ended 30th June, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 09th June, 2026.

2026-08-07

Updates

2026-08-07 - Anuh Pharma Limited has informed the Exchange regarding 'Adoption of Revised Policy of Related Party Transactions.'.

2026-08-07

Updates

2026-08-07 - Anuh Pharma Limited has informed the Exchange regarding 'Request received for Withdrawal of application for reclassification of shareholding from Promoter & Promoter Group to Public Category'.

News

Recent coverage and analyst commentary for ANUHPHR

Loading news…

🤖

AI Stock Analyst

Anuh Pharma Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

ANUHPHR

81.24

18.43

814.22

1.85

114.25

1276.51

1938.10

939.31

16.02

8.40

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

161

150

172

164

138

166

160

198

186

197

202

1,938

148

132

148

145

127

149

145

179

176

174

180

182

1,800

Operating Profit

139

OPM %

8.65%

12.01%

13.94%

11.73%

7.66%

10.17%

9.27%

9.42%

5.52%

6.39%

8.52%

9.84%

7.15%

-1

Interest

Depreciation

Profit before Tax

169

Tax %

23.75%

22.60%

24.46%

22.11%

22.49%

17.32%

22.00%

27.89%

24.20%

23.29%

24.57%

24.74%

32.51%

Net Profit

114

2.35

2.76

3.81

3.06

1.90

1.50

1.03

1.24

1.66

0.76

1.34

1.17

1.14

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

206

238

321

307

432

487

527

647

662

772

779

183

220

291

284

387

439

476

571

600

714

717

Operating Profit

OPM %

11.00%

7.70%

9.34%

7.57%

10.45%

9.75%

9.82%

11.71%

9.30%

7.44%

8.01%

Interest

Depreciation

Profit before Tax

Tax %

27.32%

29.49%

27.89%

25.32%

26.24%

21.88%

23.78%

23.31%

22.38%

24.30%

26.63%

Net Profit

EPS

0.00

5.67

6.10

7.22

11.98

9.45

4.10

—

Dividend Payout %

31.24%

41.73%

29.49%

48.17%

26.43%

28.70%

27.70%

20.86%

15.87%

36.63%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

128

137

152

150

166

189

216

266

301

302

Trade Payables

105

120

122

153

141

157

188

Total Liabilities

187

208

239

326

333

347

404

445

505

554

Capital Work in Progress

106

148

190

216

239

Cash & Bank

128

147

181

Total Assets

187

208

239

326

333

347

404

445

505

554

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-9

-3

Cash from Investing

-20

-77

-8

-43

-20

Cash from Financing

-4

-5

-7

-33

-19

-12

-9

-5

-26

-1

-5

-2

-11

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

8.00

6.59

9.33

5.71

5.67

6.10

7.22

11.98

9.45

4.10

Book Value (₹)

56.09

59.71

65.69

64.74

38.04

42.66

48.14

58.11

65.06

35.14

Dividend per Share (₹)

2.50

2.75

1.50

1.75

2.00

2.50

1.50

Cash EPS (₹)

2.20

1.83

2.50

2.13

4.34

4.24

4.58

6.85

5.60

5.23

PROFITABILITY

Operating Margin %

13.95%

10.57%

10.76%

8.63%

12.64%

10.73%

10.93%

11.65%

9.23%

7.37%

Net Margin %

9.24%

6.79%

7.25%

4.50%

6.46%

6.22%

6.83%

9.24%

7.10%

5.27%

ROE %

15.43%

11.38%

14.87%

8.75%

16.12%

15.11%

15.90%

22.56%

15.34%

12.10%

ROCE %

21.61%

16.31%

20.56%

10.87%

19.75%

19.33%

21.05%

29.66%

19.77%

16.02%

10.58%

8.35%

10.44%

5.06%

8.63%

8.99%

9.63%

14.14%

9.97%

7.76%

EFFICIENCY

Debtor Days

110

106

101

111

106

Inventory Days

Payable Days

115

131

125

117

125

111

109

105

FINANCIAL HEALTH

Debt to Equity (x)

0.00x

0.02x

0.03x

0.27x

0.07x

0.01x

0.00x

0.01x

0.03x

0.00x

Interest Coverage (x)

39.30x

52.91x

55.16x

16.23x

19.99x

25.76x

64.61x

82.82x

50.10x

57.78x

2.91x

2.63x

2.03x

1.37x

1.70x

1.98x

1.91x

2.22x

2.11x

2.22x

GROWTH

Revenue Growth %

-36.81%

15.49%

34.68%

-4.27%

40.72%

12.66%

8.39%

22.66%

2.24%

16.65%

Operating Profit Growth %

-26.27%

-15.11%

34.87%

-20.82%

102.79%

-5.38%

9.98%

51.68%

-19.20%

-6.24%

Net Profit Growth %

-22.30%

-17.65%

41.51%

-38.78%

98.78%

7.47%

18.38%

66.00%

-21.16%

-13.32%

0.00%

66.00%

-21.16%

-56.66%

VALUATION

P/E (x)

0.00x

10.25x

7.88x

16.39x

P/B (x)

0.00x

4.23x

2.29x

1.91x

Dividend Yield %

0.00%

1.02%

1.01%

2.23%

0.00x

13.94x

10.38x

9.98x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

69.92

71.82

71.80

0.03

0.02

0.04

0.00

0.05

0.01

DIIs

0.00

Government

0.00

30.05

30.06

30.05

30.04

28.18

28.16

28.19

Anuh Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Anuh Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI